What Specs does

Specs (legally Specs Compound Handling B.V.) is a Netherlands-based provider of outsourced compound management services and a supplier of screening compounds to the global life-science industry. Founded in 1987 and headquartered in Zoetermeer, the company has built an in-house repository of more than 350,000 drug-like small molecules, sourced through a global acquisition network of more than 2,000 academic partners in over 45 countries, and offers natural products, building blocks, an academic compounds database (ExAcD), pre-plated libraries, and custom synthesis support. Core operations run from two logistics hubs in Zoetermeer (1,500 sqm) and Cumberland, Maryland (2,000 sqm), supported by Echo Liquid Handlers, Kardex Remstar temperature-controlled storage, automated weighing and QC devices, and fireproof seismic-rated vaults for disaster-recovery storage.

The company monetizes through two complementary streams: one-time sales of compounds (minimum 1mg, with 90%+ re-supply rates and >95% typical purity) via its specs.net online portal, and multi-year outsourced compound management services including procurement, reformatting, warehousing, quality control, cheminformatics, and on-site staffing embedded at customer facilities. Go-to-market is sales-led and direct-to-enterprise, targeting top-15 global pharmaceutical companies (Roche, AstraZeneca, Johnson & Johnson, Merck, Boehringer Ingelheim among named clients), alongside biotechnology firms, academic and research institutions, and nonprofits such as Medicines for Malaria Ventures. Distribution is global with daily shipments and regional sales offices in China, India, and Japan.

In May 2023 Specs was acquired by eMolecules, Inc. (backed by Avista Capital Partners) and now operates as part of the eMolecules brand, combining compound management infrastructure with a chemical search-and-fulfillment platform. The company has 11–50 employees, was the first compound supplier to launch an online chemical search engine in 2000, and has earned 2024 EcoVadis Bronze and CDP SME Climate Score B recognitions for sustainability performance.

Name

Specs

Legal name

Specs Compound Handling B.V.

Website

https://specs.net

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Compound Management Services

NAICS

Chemical and Allied Products Merchant Wholesalers (4246), Other Chemical and Allied Products Merchant Wholesalers (42469)

SIC

Wholesale-Chemicals & Allied Products (5160), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Supply, Logistics & Vendor Management FSP (HLAGAOAH)

akta.pro secondary industry

Chemicals, Ingredients & Raw Materials Marketplaces (CRAFAHAK)

Keywords

• Compound management services
• Screening compound supply
• Drug discovery chemistry
• Research compound libraries
• Custom synthesis services

Headquarters

HQ city

Zoetermeer

HQ country

Netherlands

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Compound Sales and Sourcing: Sale of research compounds from in-house repository of 350,000+ screening compounds, building blocks, and natural products to pharmaceutical, biotechnology, and academic customers. Compounds are supplied in various formats including vials, plates, and custom packaging.
2. Compound Management Services: Outsourced compound management services including weighing, plating, storage, quality control, and distribution for clients. Services performed at client sites or at Specs facilities in Netherlands and Maryland, USA.
3. Custom Synthesis and Contract Research: Custom synthesis and contract research services for compounds not commercially available, as well as hit discovery, hit confirmation, hit expansion, and lead optimization programs.
4. Cheminformatics Services: Cheminformatic service for target specific selections for lead discovery and optimization programs, design of new chemical entities, scaffold hopping, and pharmacophore searching.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Specs provides outsourced compound management services including procurement, reformatting, warehousing, compound storage, quality control, and cheminformatics, performed either at client sites or at Specs' logistics centers in the Netherlands and Maryland, USA. The company also sells screening compounds, natural products, building blocks, academic compounds, and pre-plated libraries from its in-house repository of 350,000+ drug-like small molecules, and offers custom synthesis and contract research for hit-to-lead and lead optimization programs.

Product overview

Specs (now part of eMolecules) operates as a comprehensive chemical compound sourcing and management company offering a unified portfolio of products and services for drug discovery. The core offering centers on compound management services—outsourced storage, weighing, reformatting, and distribution of research compounds—served from facilities in The Netherlands and Maryland, USA. The product portfolio includes the Screening Compounds Library (350,000+ compounds), Natural Products (~800 compounds), Building Blocks, Academic Compounds Database (ExAcD), and Pre-plated Compound Libraries. Supporting services include Custom Synthesis, Cheminformatics Services, and the Specs.net Online Platform for structure-based searches and ordering. The company positions itself as a one-stop solution provider, integrating compound procurement, management, reformatting, and inventory management services.

Differentiator

Problem solved

Functional benefit

Brands

• Specs.net: Online platform for ordering chemical compounds and accessing compound library data
• Specs Fragments library
• Exciting Academic Database (ExAcD)
• World Diversity Set (WDS3)

Products and services

• Compound Management Services Outsourced compound management services including procurement, reformatting, warehousing, compound storage, quality control, cheminformatics, and on-site/off-site handling for pharmaceutical, biotechnology, and academic customers.
• Screening Compounds Library In-house catalog of nearly 300,000 compounds available in 1 mg amounts and over 200,000 compounds in 10 mg+ quantities, with molecular weight 175–500 Dalton and purity of at least 90% (typical >95%).
• Natural Products Diverse set of isolated and synthesized natural products from plants, fungi, marine organisms, and bacteria with purity >80%, comprising approximately 800 products in stock.
• Building Blocks Catalogue Non-commercially available solid small heterocyclic compounds with molecular weight under 350 Dalton containing two or more chemical handles for medicinal chemistry use.
• Academic Compounds Database (ExAcD) Unfiltered collection of compounds from academic and research institutes worldwide, available for download through customer accounts with longer delivery times; database exceeds 492,534 entries.
• Pre-plated Compound Libraries Pre-selected targeted or diverse libraries available in 96-, 384-, and 1536-well plates for assay-ready screening, including the Specs Fragments library and the 10,000-compound World Diversity Set (WDS3).
• Custom Synthesis and Contract Research Custom synthesis of compounds not commercially available plus contract research services covering hit discovery, hit confirmation, hit expansion, hit-to-lead, and lead optimization programs, performed by in-house laboratory chemists.
• Cheminformatics Services Target-specific compound selections for lead discovery and optimization programs, design of new chemical entities, scaffold hopping, and pharmacophore searching.
• Specs.net Online Platform Online chemical search engine and ordering portal for the Specs catalog, enabling structure-based search, compound ordering, access to analytical data, and download of compound library information through registered user accounts.

Quantifiable outcome

• Re-supply rate of over 90%
• +3 more outcomes

Named customers13 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and major.

• eMolecules, Inc.coreStrategic or Co-development Partner · 24 May 2023eMolecules acquired Specs Compound Handling B.V. on May 24, 2023. The acquisition combines Specs' compound management services with eMolecules' chemical compound search-and-fulfillment platform, creating a global one-stop shop for streamlined chemical compound procurement and management services. Specs now operates as part of the eMolecules brand, simplifying customer experience while enhancing compound sourcing and management capabilities.
• Medicines for Malaria Ventures (MMV)majorStrategic or Co-development PartnerSince 2012, Specs has managed storage and full compound management for MMV in Geneva, Switzerland. Daily compound delivery from external partners, QC analysis, weighing, plating and worldwide shipping. Secure online ordering interface enables real-time sample tracking.
• Alion PharmaceuticalsmajorStrategic or Co-development PartnerOncology and CNS screening programs partnership for hit discovery and lead optimization using Specs' compound libraries.
• OncodronemajorStrategic or Co-development PartnerProstate cancer metastasis and Oncology program collaboration with Specs for compound screening and drug discovery support.
• OcellOmajorStrategic or Co-development PartnerPolycystic kidney disease screening program partnership for hit discovery using Specs' compound management services.
• University Medical Centre UtrechtmajorStrategic or Co-development PartnerResearch collaboration for growth hormone receptor inhibitors to cure cancer, utilizing Specs' compound libraries and cheminformatics expertise.
• ThrombotargetsmajorStrategic or Co-development PartnerAnticoagulant program collaboration for hit discovery and lead optimization using Specs' screening compounds.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• ChemSpace: ChemSpace is a marketplace and contract research provider for building blocks, screening compounds, and custom synthesis, overlapping with Specs' catalog compound supply and cheminformatics-enabled sourcing services.
• Life Chemicals: Life Chemicals supplies diverse screening libraries, building blocks, and custom synthesis services to pharma and biotech customers, comparable in scope to Specs' screening compound library and hit-to-lead research offering.
• Combi-Blocks: Combi-Blocks is a supplier of screening compounds and chemical building blocks to the drug discovery industry, directly competing with Specs for catalog compound sales to pharma and biotech customers.
• Enamine: Enamine is a major supplier of screening compounds and building blocks for drug discovery with a similarly large in-house compound library. It competes directly with Specs on catalog compound supply and custom synthesis services to pharma and biotech screening programs.
• MolPort: MolPort operates a chemical compound marketplace aggregating multiple suppliers and provides structure-based compound search and sourcing, directly comparable to Specs' online compound search and procurement offering at specs.net.
• eMolecules: eMolecules is the chemical compound search-and-fulfillment platform that acquired Specs Compound Handling B.V. in May 2023, and now operates the Specs brand under its umbrella. Together they offer a combined compound sourcing marketplace plus outsourced compound management services, the most direct comparable in product and customer base.
• Princeton BioMolecular Research: Princeton BioMolecular Research provides screening libraries, custom synthesis, and compound management services for drug discovery, closely mirroring Specs' combination of catalog compounds plus outsourced compound handling.

Broad incumbents

• WuXi AppTec: WuXi AppTec is a large global CRO/CDMO with adjacent preclinical chemistry, compound management, and custom synthesis capabilities for pharma. It is a much broader incumbent but its chemistry services division competes with Specs for outsourced compound work.
• Tocris Bioscience (Bio-Techne): Tocris, part of Bio-Techne, is a leading supplier of life science research reagents including pharmacological compounds for screening. It overlaps with Specs' research compound supply but operates within Bio-Techne's much broader reagents and tools portfolio.
• MilliporeSigma (Merck KGaA Life Science): MilliporeSigma offers an extensive catalog of chemicals, reagents, and lab supplies used across drug discovery. While not specialized in compound management, it is an incumbent vendor that competes broadly for catalog compound and reagent spend at shared pharma and academic customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/specs

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Specs